Eastsea

Qingdao Eastsea Pharmaceutical Co., Ltd. is a national high-technology enterprise that was established by Chairman Cui YunLong and joint-stock by State Development & Investment Corp. Its registered capital is US$ 13 Million and it has a 25-hectare insdustrial park.

Qingdao Eastsea Pharmaceutical Co., Ltd. is the first national demonstration project of probiotics medicine supported by the National Development and Reform Commission. At first the National Development and Reform Commission supported US$1.3million free of charge, approved the joint-stock of US$ 5.6 Million of its State Development & Investment Corp, Its purpose is to support the construction and development of probiotics medicine industry.

Qingdao Eastsea Pharmaceutical Co., Ltd. assumed 4 projects of the “863" research program of the National Ministry of science and technology. In 2010, together with other seven research institutes and Universities, such as No. 3 National marine institutes, Shandong University and Ocean University of China, we assumed the national marine scientific research project.

Qingdao Eastsea Pharmaceutical Co., Ltd is also the editor of the probiotics part of the 2010 edition of Chinese Pharmacopoeia, and won about US$240 Million national research fund.

Now Qingdao Eastsea Pharmaceutical Co., Ltd takes possession of 32 China and the United States patents, which ensures exclusive rights of the production and marketing for a long time of 20 years, no matter in China market or the United States Market. All of above is the fundation of our long-term and continuable development and the powerful market-protection for our partners.

After 7-year effort, the returned Doctor team after overseas-educated with the captain of Chairman Cui Yunlong, researched successfully, possessed our own property rights and broke Japan international monopoly, then developed new probiotics medicine and supplement as below:

Nutrition BC ™ -Bacillus coagulans Tablets 　 　 　 　 　 　 　 Beauty BC ™ -Bacillus coagulans Powder

We invented unique technology of the anaerobic and prolific bacteria, then broke the bottleneck of 2～8℃ low-temperature storage of the probiotics. Based on above, we are honored as:

The National key new products 　　 The National High-tech products 　 　 The National Torch Program　 　 The National 863 Program

Since August 2006 we launched our probiotics medicine and supplement in the Chinese market, our probiotics medicine quickly won the high indentification of the majority of pediatric specialists, doctors and parents by significant curative effect and no side effect on the treatment of diarrhea, constipation, jaundice, prevention of NEC, eczema, recurrent respiratory tract infections and other diseases, for example, Clostridium butyricum capsule succeed in cure 27 years chronic diarrhea for Academician Yuan Longping- The Father of Hybrid Rice; Our probiotics supplement is also warmly welcomed by the majority of consumers by helping to strength digestive system & immune system and helping to defense against occasional digestive upsets.

Qingdao Eastsea Pharmaceutical Co., Ltd takes the people health all over the world as our responsibility, is willing to popularize the probiotic knowledge with our doctor and people in common and promote the probiotic products. Our purposes are as belows:

To wake up our people to establish a concept of that protecting intestinal flora means to protect our health and life.
To promote the popularization and use of the probiotic products, to eliminate the antibiotic use, then to improve our people health all over the world.

Our Honors